Novel Nucleoside Reverse Transcriptase Inhibitor Derivatives for Chronic Neuropathic Pain

Pharmacology, Toxicology and Pharmaceutical Science

1. Abacavir 18%
2. Adenosine Triphosphate 18%
3. Adverse Effect 9%
4. Analgesic Agent 9%
5. Bacterial Toxin 9%
6. Cell Culture 9%
7. Cholesterol 9%
8. Chronic Inflammatory Pain 9%
9. Chronic Pain 18%
10. Cytokine 9%
11. Deoxyguanosine 9%
12. DNA Polymerase 9%
13. Drug Absorption 9%
14. Elimination 9%
15. Enzyme-Linked Immunosorbent Assay 9%
16. Ethambutol 9%
17. Fatty Liver 9%
18. Genotoxicity 9%
19. High Performance Liquid Chromatography 9%
20. HIV 9%
21. Hyperalgesia 9%
22. Inflammasome 63%
23. Inflammatory Pain 18%
24. Interleukin 1 18%
25. Interleukin 18 9%
26. Interleukin 1beta Converting Enzyme 36%
27. Knockout Mouse 9%
28. Lactic Acidosis 9%
29. Lamivudine 36%
30. Mechanical Allodynia 9%
31. Mechanical Hyperalgesia 9%
32. Mitochondrial DNA 9%
33. Multiprotein Complex 9%
34. Nerve Injury 9%
35. Nerve Transection 9%
36. Neuropathic Pain 100%
37. Neuropathy 9%
38. Pharmacokinetics 9%
39. Placebo 9%
40. Purinergic P2X7 Receptor 27%
41. Receptor 9%
42. Reverse Transcriptase 18%
43. RNA Directed DNA Polymerase Inhibitor 100%
44. Stavudine 45%
45. Synapsin II 54%
46. Virus 9%
47. Western Blot 9%
48. Zalcitabine 9%
49. Zidovudine 54%